TGFB1 and systemic mastocytosis: Conversely, children with SM had lower levels of TGF-β1 and IL-12 (P < 0.001 and P = 0.039, respectively; Figure 3B and 3C), and lower prevalence of detectable IL-12 concentrations than matched UM controls (P = 0.011; Figure 3C).